Compounds > phaseollidin
Page last updated: 2024-09-03

phaseollidin and ursolic acid

phaseollidin has been researched along with ursolic acid in 1 studies

Compound Research Comparison

Studies
(phaseollidin)		Trials
(phaseollidin)		Recent Studies (post-2010)
(phaseollidin)		Studies
(ursolic acid)		Trials
(ursolic acid)		Recent Studies (post-2010) (ursolic acid)
6021,577101,083

Protein Interaction Comparison

ProteinTaxonomyphaseollidin (IC50)ursolic acid (IC50)
Aldo-keto reductase family 1 member B10Homo sapiens (human)4
Glycogen phosphorylase, muscle formOryctolagus cuniculus (rabbit)8.9708
Basic phospholipase A2 1Naja melanoleuca (forest cobra)2.9
DNA polymerase betaRattus norvegicus (Norway rat)6.65
Neutrophil elastaseHomo sapiens (human)0.416
Receptor-type tyrosine-protein phosphatase FHomo sapiens (human)3.8
Tyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)4.1433
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)3.8872
Liver carboxylesterase 1Homo sapiens (human)0.1
Low molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)7.2
Corticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)1.9
Delta-type opioid receptorMus musculus (house mouse)3.6
Nuclear receptor ROR-gammaHomo sapiens (human)3.5333
Basic phospholipase A2 PLA-AProtobothrops flavoviridis2.5
Transcription factor p65Homo sapiens (human)0.031
Acidic phospholipase A2 EC-IEchis carinatus (saw-scaled viper)2.3
Ubiquitin carboxyl-terminal hydrolase 7Homo sapiens (human)7
Sentrin-specific protease 1Homo sapiens (human)1.2932
Protease Human immunodeficiency virus 18

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dao, TT; Kang, KW; Le, TV; Mbafor, JT; Ndinteh, DT; Nguyen, PH; Oh, WK; Thuong, PT1

Other Studies

1 other study(ies) available for phaseollidin and ursolic acid

ArticleYear
Cytotoxic and PTP1B inhibitory activities from Erythrina abyssinica.
    Bioorganic & medicinal chemistry letters, 2009, Dec-01, Volume: 19, Issue:23

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Erythrina; Humans; Molecular Structure; Plant Bark; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Stereoisomerism

2009